Loading...
XJPX
9627
Market cap1.21bUSD
Oct 09, Last price  
5,423.00JPY
1D
0.06%
1Q
-2.90%
Jan 2017
-29.94%
Name

AIN Holdings Inc

Chart & performance

D1W1MN
XJPX:9627 chart
P/E
11.04
P/S
0.29
EPS
491.18
Div yield, %
1.48%
Shrs. gr., 5y
-0.18%
Rev. gr., 5y
16.86%
Revenues
647.83b
+41.82%
81,307,000,000106,231,000,000115,387,000,000125,495,820,000129,387,173,000142,790,684,000154,560,620,000170,225,754,000187,904,956,000234,843,598,000248,110,130,000268,385,000,000275,596,000,000292,615,000,000297,305,000,000316,247,000,000358,742,000,000399,824,000,000456,804,000,000647,834,000,000
Net income
17.27b
+86.43%
1,010,000,0001,615,000,0002,127,000,0003,131,216,0003,916,991,0004,899,402,0005,075,114,0005,259,398,0006,197,170,0007,917,117,0007,949,400,00010,567,000,0009,030,000,0009,180,000,0006,696,000,0007,092,000,0009,235,000,00011,402,000,0009,261,000,00017,265,000,000
CFO
30.87b
+33.38%
2,277,000,0008,423,000,0004,333,000,0006,428,462,0007,627,098,00011,679,655,00010,203,704,00014,662,828,00014,839,947,00021,352,361,00018,409,088,00021,656,000,00014,788,000,00017,747,000,00014,928,000,00026,156,000,00020,267,000,00023,023,000,00023,146,000,00030,872,000,000
Dividend
Apr 28, 2026100 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Ain Holdings Inc. is a Japanese corporation primarily involved in pharmaceutical dispensing and the management of cosmetic and drug retail outlets. Its dispensing pharmacy division oversees numerous pharmacies, distributes generic medicines, and offers both personnel placement and advisory services. Concurrently, the cosmetic and drug store segment manages stores operating under the AINZ & TULPE brand. The company's other operations include running various retail establishments and engaging in real estate rental. As of April 30, 2021, Ain Holdings operated 1,065 dispensing pharmacies and 69 cosmetic and drug stores. Established in 1969, the company was formerly known as Ain Pharmaciez Inc. before adopting its current name in November 2015, and its headquarters are located in Sapporo, Japan.

Key people

Kiichi Otani
President, Representative Director · since 1988
Toshihide Mizushima
Senior Managing Director, Chief Senior Director of Retail Operations, President of Subsidiary, Representative Director · since 2024
Miya Ohishi
Senior Managing Director, Representative Director · since 2023
Hidehiro Awaji
Senior Executive Officer, Chief Senior Director of Development · since 2024
Toshiya Wada
Senior Executive Officer, Chief Director of Digital Promotion, Director of Operations System · since 2024
Susumu Watanabe
Senior Executive Officer, Chief Director of Pharmaceutical Management · since 2024
Terumi Yoshimura
Senior Executive Officer · since 2024
Rieko Kimei
Chief Director of Human Resources, Director · since 2022
Yoshihiro Hirako
Executive Officer, Director of Sales Planning in Main Development Supervision Unit · since 2024
Hisashi Igarashi
Executive Officer · since 2023
Kento Ikeda
Executive Officer, Director of Corporate Information · since 2024
Takako Ishiguro
Executive Officer, Deputy Chief Director of Pharmaceutical Operations Supervision Unit · since 2025
Tamami Maki
Executive Officer, Director of Retail Strategy in Retail Business Supervision Unit · since 2025
Yasuhiro Okuda
Executive Officer, Deputy Chief Director of Main Pharmaceutical Management Supervision Unit, Director of Operations Planning · since 2024
Masashi Sano
Executive Officer, Director of Safety Measures in Main Pharmaceutical Management Supervision Unit · since 2024
Nanae Suzuki
Executive Officer · since 2025
Takayuki Tsuboi
Executive Officer, Director in charge of Main Sales Supervision Unit · since 2024
Keiji Yoshikawa
Executive Officer, Director of Regional Collaboration in Main Pharmaceutical Management Supervision Unit · since 2024
Shoichi Shudo
Senior Managing Director, President of Subsidiary, Representative Director · since 2024
Nobuyuki Takakura
Chief Director of Sustainability Promotion, Director · since 2025
URL
http://www.ainj.co.jp
IPO date
Mar 18, 1994
Employees
10,561
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑042025‑042024‑042023‑042022‑042021‑042020‑042019‑042018‑042017‑04
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT